Recent studies on small series of pancreatic cancer (PC) with foci of pancreatic intraepithelial neoplasia (PanIN), a putative precursor lesion, have shown that multiple K-RAS mutations may coexist in the same neoplastic pancreas. To see whether mutant-K-RAS polyclonality is a common and speci®c feature of pancreatic carcinogenesis, we investigated a unselected series of periampullary cancers (41 pancreatic, 13 biliary and two ampullary adenocarcinomas). After hemi-nested polymerase chain reaction (PCR), mutations identi®ed with single strand conformation polymorphism (SSCP) were con®rmed by allele-speci®c PCR and sequencing. K-RAS codon 12 was mutated in 34 (83%) pancreatic cancers and in 11 (85%) biliary cancers. Multiple distinct K-RAS mutations were found in 16 PC (39% of all cases, 47% of those with mutated K-RAS) and in eight biliary cancers (62 and 72%, respectively). In PC, multiple K-RAS mutations were more frequent (P50.001) in cancers with (nine of 12, 75%) than in those without detectable PanIN (seven of 29, 24%). Individual precursor lesions of the same neoplastic pancreas were found to harbor distinct mutations. Results show that multiple K-RAS mutations are frequent both in PC with associated PanIN and in biliary cancers, and indicate that clonally distinct precursor lesions of PC might variably contribute to tumor development.
Introduction
K-RAS point mutations at codon 12 (from GGT to GAT, or to GTT and, more rarely, to CGT) occur in 75 to 95% of PC, a frequency not encountered in any other solid neoplasm (Almoguera et al., 1988; Hruban et al., 1993) . K-RAS activation has been recognized also in microdissected foci of PanIN, the candidate precursor lesion of PC previously known as ductal cell hyperplasia (Cubilla and Fitzgerald, 1976; Hruban et al., 2000a,b) . The frequency of K-RAS mutations was found to be higher in hyperplastic foci associated with pancreatic cancer (65% to 75%), than in those associated with chronic pancreatitis (62%), or detected at necropsy in otherwise normal pancreas (24%) (Caldas et al., 1994; Yanagisawa et al., 1993; Tada et al., 1996) . A major role of K-RAS mutation in committing hyperplastic areas to cancer development was then postulated. However, hyperplastic foci were recognized to harbor a spectrum of point mutations of K-RAS codon 12 broader than that usually observed in cancer tissue (Tada et al., 1996; Urrutia and Di Magno, 1996) . In addition, it was noticed that multiple distinct K-RAS mutations may coexist, in the same pancreas, in putative precursor lesions and in cancer tissue (Caldas et al., 1994; Moskaluk et al., 1997) .
In this study, a series of unselected periampullary tumors was investigated for codon 12 K-RAS point mutations by a highly sensitive PCR technique and SSCP analysis. The aims were to see whether the occurrence of clones with dierent K-RAS substitutions is a frequent feature of PC, whether it correlates with the presence of precursor lesions, and whether K-RAS mutations polyclonality is speci®c of PC versus biliary tumors.
Results
Abnormal SSCP patterns indicating K-RAS mutations, were detected in 34 (83%) PC, and in 11 (85%) distal bile duct cancers, whereas a normal electrophoretic pro®le was seen in the two ampullary tumors.
A substantial fraction of abnormal SSCPs showed, at repeated experiments, more bands than those expected in the presence of a single point mutation, suggesting the coexistence of distinct multiple mutations. In such cases, almost invariably, one of the SSCP abnormal bands was fainter than the other, and was no longer detectable if the same tissue was reprocessed with a second round PCR of less than 30 cycles. Examples of SSCP screening for K-RAS mutations in PC tissues, including cases with complex patterns, are shown in Figure 1 .
Allele-speci®c PCR and sequencing of excised individual bands of all abnormal SSCPs con®rmed the existence of cases with more than one mutation within the same tissue (Figure 2) . Table 1 summarizes the frequencies of dierent K-RAS patterns observed in PC and in biliary cancer tissues. In PC, a single point mutation was observed in 18 tissues (44% of all cases, 53% of those with mutated K-RAS), GAT and GTT substitutions accounting for nine cases each. Two distinct mutations were detected in 16 cases (39% of all PC and 47% of those with activated K-RAS), GAT coexisting with GTT in 13 cases and with CGT in three cases. In two cases (one PC and one bile duct cancer), a mutation at codon 13 coexisted with two dierent substitutions at codon 12.
Distinct coexisting K-RAS mutations were frequent also in bile duct cancers ( Figure 3 and Table 1 ). A single mutation was found in three cases (23% of all cases, 27% of those with mutated K-RAS), whereas a bi-mutational pattern was con®rmed in eight cases (62 and 72%, respectively).
The frequency of bi-mutational pattern in PC was signi®cantly higher (P50.001) in PC tissues with associated PanIN (75% of all cases, 90% of those with K-RAS mutation) than in sections without histologically evident precursor lesions (24 and 29%, respectively) ( Table 2) . Examples of such lesions are given in Figure 4 . No dierence between the two subgroups of PC tissues was observed as to the frequency of wild-type K-RAS exon 1 (17% of cases).
In ®ve of 12 PC with associated PanIN, mutational analysis of individual precursor lesions was performed after microdissection ( Figure 5 ). In 2 PC exhibiting a K-RAS bimutational pattern, GAT and GTT mutations, as well as wild-type K-RAS, were separately found in dierent precursor lesions. In one wild-type K-RAS PC, a GTT mutation was newly recognized in one of three tested lesions. Finally, in a GAT-mutated PC, the same mutation was detected in all tested precursor ductal lesions (Table 3) . Dierently from microdissection of PanINs,`blind' microdissection of portions of PC with bimutational pattern never identi®ed areas with a single K-ras mutation.
Discussion
In a series of unselected periampullary tumors, polyclonality for K-RAS mutation was found to be a common feature of PC, with an overall prevalence of 39% (47% of cases with mutated K-RAS). Our results con®rm and extend data by Moskaluk et al., who found distinct K-RAS mutations in ®ve of 10 PC specimens preselected for the presence of associated precursor lesions (Moskaluk et al., 1997) . In most of our cases, one of the coexisting mutations was largely One case with a third AGC mutation at codon 13 K-RAS coexisting mutations in pancreato-biliary cancers L Laghi et al more represented than the other (see Results and Figures 2, 3 and 4), so that even higher prevalences of bimutational pattern can be expected with more sensitive analytical techniques. In particular, current methods might fail to detect poorly represented GAT mutations coexisting in GTT mutated cancers. Looking for multiple K-RAS mutations in PC, we did not preselect specimens with pancreatic intraductal changes. This was mainly dictated by the fact that the histopathologic criteria for distinguishing neoplastic from non-neoplastic epithelial changes in pancreatic ducts are not precisely de®ned (Kern, 1998) . As a matter of fact, diculties in recognizing precursor lesions to in®ltrating PC have been reported by experienced pathologists even after the recent development of a new nomenclature for classi®cation of proliferative duct lesions (Hruban et al., 2000a,b; . Moreover, we wanted to evaluate the overall occurrence of K-RAS polyclonality in PC, independently of tumor morphology at time of resection. However, at restrospective analysis of data, we did ®nd a signi®cantly higher frequency of multiple K-RAS mutations in specimens of PC with associated PanIN foci than in those without histologic evidence of such lesions (75 vs 24%; P50.001). In addition, individual precursor lesions of PC with multiple K-RAS mutations were found to harbor only one mutation, dierent lesions theoretically accounting for the complex mutational pattern of unmicrodissected tissue. Yet, the weakness of mutant bands from single precursor lesions, as well as the coexistence of distinct mutations in microareas of cancer, indicate that genetic heterogeneity within the tumor cell population is the most likely explanation for the detection of multiple K-RAS mutations. Along this line of interpretation, cancer-associated non malignant K-RAS mutated PanINs might simply represent carcinogenesis relics or, alternatively, not yet clonally expanded lesions of that neoplastic pancreas. At any event, our ®ndings strongly indicate that, in the same pancreas, morphologically indistinguishable candidate precursor lesions harbor cells with distinct K-RAS mutations, and that their clonal expansion might variably contribute to full development of PC. The frequency of K-RAS mutation in PC precursor lesions is known to be higher in histologically advanced papillary lesions than in nonpapillary ductal changes (Yanagisawa et al., 1993; Caldas et al., 1994; Moskaluk et al., 1997) . In addition, genetic alterations other than K-RAS mutation can be found in PC precursors (Yamano et al., 2000) . Therefore, K-RAS cannot be safely proposed as a gatekeeper gene for pancreatic Oncogene K-RAS coexisting mutations in pancreato-biliary cancers L Laghi et al neoplasia. However, K-RAS mutation is currently thought to be an early genetic event associated with tumor initiation, whereas additional genetic damage (such as P16, P53, or DPC4 inactivation) would be necessary for progression of precursor lesions to PC (Hruban et al., 2000a,b; Moskaluk et al., 1997; Tada et al., 1996; Rozemblum et al., 1997; Kern, 1998) . In this model, the additional genetic changes would hit ductal cells bearing an activating K-RAS mutation thus leading to tumor commitment of the emerging clone (Hruban et al., 2000a,b) . In this respect, the demonstration of K-RAS polyclonality in PC with PanIN, raises issues such as the individual risk for dierent clones of undergoing further genetic damage, and even the possibility that neoplastic clones may compete in the course of tumor progression. We investigated a series of unselected periampullary tumors to see if mutated K-RAS polyclonality was a feature speci®c of PC rather than shared with biliary cancers. A 60% prevalence of multiple K-RAS mutations had been originally reported in a series of 15 extrahepatic cholangiocarcinomas (Levi et al., 1991) , but following studies gave controversial results, and the frequencies of K-RAS mutation in these tumors ranged from 8 to 80% (Motojma et al., 1991; Watanabe et al., 1994) . In the present study, a bimutational pattern was observed in eight of 13 biliary cancers (63% of all cases and 72% of the 11 cases with K-RAS mutation), a prevalence even higher than that found in PC (P50.01). Thus, our results conclusively demonstrate that distal bile duct tumors have a very high frequency both of mutated K-RAS, and of K-RAS polyclonality. This ®nding con®rms that the occurrence of multiple K-RAS mutations is a common event in malignancies sharing early RAS activation, the phenomenon being possibly overlooked when insuciently sensitive methods are used. Consistently, multiple distinct K-RAS mutations have been also described in subsets of colorectal cancer (Forrester et al., 1987; Zhu et al., 1997; Yashiro et al., 2001) . In summary, multiple and coexisting K-RAS mutations are a common genetic feature both of PC with associated PanIN and of bile duct cancers. In PC, dierent neoplastic precursor lesions may be clonal as to the type of K-RAS mutation. A model of pancreatobiliary carcinogenesis in which distinct K-RAS-mutated clones contribute an individual risk of developing the further genetic damage necessary for cancer progression, is consistent with these ®ndings.
Materials and methods

Tissue samples
Hematoxylin-eosin stained slides of 80 consecutive periampullary tumors, surgically resected at the Department of Surgery of the San Raaele Hospital in Milan, were preliminary reviewed. Only paran-embedded tissue blocks with a neoplastic cellularity above 40%, corresponding to 56 cases, were used in the study. The ®nal pathological diagnosis was pancreatic adenocarcinoma in 41 cases, distal bile duct adenocarcinoma in 13, and ampullary adenocarcinoma in two cases.
Prior to molecular genetic analysis, all PC sections were carefully evaluated by two dedicated pathologists for the presence of putative precursor lesions de®ned as¯at or papillary areas with variable degrees of nuclear abnormalities and mitotic ®gures (PanIN one to three) (Hruban et al., 2000a) .
Molecular genetic analysis
To obtain crude DNA, two 5 mm sections of each tissue specimen were treated with xylene and digested by proteinase K (200 mg/ml). Ampli®cation of K-RAS exon 1 was accomplished with a hemi-nested polymerase chain reaction (PCR) technique. The ®rst round, hot-started PCR (using Ampliwax Gems, Perkin-Elmer, Branchburg, NJ, USA) was performed in a volume of 50 ml, containing 2 mM MgCl 2 , 0.2 mM dNTPs, 20 pmol of each primer (Forward Long, CGT CCA CAA AAT GAT TCT GAA TTA GCT GTA TC; Reverse Long, CCT TAT GTG TGA CAT GTT CTA ATA TAG TCA C), and 1 U of Taq polymerase (Perkin-Elmer) in the supplied buer. The ®rst cycle was run at 948C for 2 min and 698C for 1 min, followed by 29 more cycles at 948C for 30 s and 698C for 30 s with a ®nal extension at 728C for 5 min. One ml of the ®rst round PCR-product was then transferred to 50 ml of fresh PCR mixture containing 1.5 mM MgCl 2 , 0.2 mM dNTPs, 10 pmol of each primer (Forward Short AGG CCT GCT GAA AAT GAC, and the same reverse primer above described), and 1 U of Taq polymerase.
The ®rst cycle (at 948C for 2 min, at 558C for 30 s, at 728C for 30 s), was followed by 35 additional cycles (at 928C for 30 s, at 558C for 30 s, at 728C for 30 s), with a ®nal extension at 728C for 5 min. SSCP were analysed according to a previously described method . Brie¯y, 5 ± 7 ml of ®nal amplicons were electrophoresed on 15% polyacrylamide minigels (Hoeer SE200, Amersham Pharmacia Biotech, Uppsala, Sweden), at 200 V for 210 min. Gels were stained using a modi®ed silver-staining procedure . The SSCP pattern of PCR products from lymphocytes of healthy subjects was used as control for wild-type K-RAS exon 1, whereas patterns of amplicons from PANC-1 and SW480 cell lines were used to characterize GAT and GTT K-RAS mutations at codon 12, respectively. SSCP sensitivity in detecting mutated K-RAS alleles was assessed by amplifying scalar amounts of DNA from SW480 and PANC1 cell-lines over the background contributed by 1 mg of human normal DNA (Human COT, Gibco, Karlsruhe, Germany). The detection limit of the system resulted to be one mutated allele among 12 000 normal alleles for the GAT mutation, and one among 60 000 copies of wildtype allele for the GTT mutation ( Figure 6 ). The dierent sensitivity in detecting GTT and GAT mutations might simply re¯ect a better electrophoretic resolution of SSCP bands generated by a GTT mutation. However, a better sensitivity for the GTT mutation, possibly due to a higher eciency of in vitro ampli®cation, has been reported also with allele-speci®c PCR (Tada et al., 1993) .
To con®rm SSCP comparative analysis, as well as to characterize SSCP dierent from those of control references, bands were excised from the gel. Mutated DNA was enriched with an allele-speci®c PCR (Sherratt et al., 1996) , and then sequenced by cycle-sequencing (AmplyCycle Sequencing kit, Perkin Elmers).
For each specimen, experiments were always performed at least twice. Sequences from repeated experiments were also obtained to con®rm any SSCP bi-mutational pattern. In ®ve of 12 PC with associated PanIN, microdissection analysis of precursor ductal lesions was performed using hematoxylinstained, 5-mm-thick tissue slides. Brie¯y, ductal lesions were individually picked-up from slides (at 106magni®cation), using sterile lancets. Each lancet was rinsed in a vial containing 16PCR buer and discharged. The hot-started hemi-nested ampli®cation was then performed under the above described conditions.
Statistical analysis
The Fisher's Exact Test was used to compare the frequency of coexisting mutations in pancreatic cancers with and without putative precursor lesions.
